Atlas Trials

Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

Clinical trial NCT04345315 · UNKNOWN

Trial details

NCT number
NCT04345315
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19SARS-CoV-2
Start date
2020-03-27
Primary completion
2021-03-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.